期刊文献+

甘露聚糖肽联合化疗对胃癌的疗效观察 被引量:3

The Curative Effect Observation of Mannatide Combined with Chemotherapy to Treat Gastric Cancer
下载PDF
导出
摘要 目的:观察甘露聚糖肽序贯治疗与放化疗联合应用治疗胃癌的疗效。方法:102例Ⅳ期胃癌住院患者,男性62例,女性40例,平均58岁,随机分为试验组和对照组,各51例。两组给予常规治疗:多西紫杉醇+氟尿嘧啶+顺铂(DCF化疗),试验组加用甘露聚糖肽序贯治疗;对照组加用胸腺肽序贯治疗。观察指标:(1)生存质量:评价中位生存期和治疗结束后1年的生存质量评分。(2)免疫学指标:CD4、CD8、CD4/CD8、外周血白细胞、抗体(IgA、IgG、IgM)、补体(C3)、中性粒细胞;(3)不良反应:恶性呕吐等放化疗常见不良反应。结果:试验组与对照组相比,治疗结束后1年的卡氏评分和中位生存期均有显著性差异(P<0.05);治疗后试验组各免疫指标较对照组改善明显,尤其是CD4/CD8(比值)、补体(C3)、外周血白细胞及中性粒细胞水平有显著性意义(P<0.01);化疗带来不良反应发生率试验组较对照组显著降低(29%比71%,P<0.01)。结论:甘露聚糖肽序贯治疗与放化疗联合应用,治疗晚期胃癌,可显著提高患者生存质量,全面增强患者免疫功能,减低放化疗带来的副作用,效果优于胸腺肽序贯治疗。 Objective:To observe the effect of sequential therapy of mannatide combined with chemotherapy to treat gastric cancer.Methods:102 hospitalized patients with gastric cancer were randomized into treatment group and control group.Each group received conventional therapy(DCF chemotherapy).The treatment group was given the sequential therapy of mannatide.The control group received the sequential therapy of thymosin.Outcome measures:(1) Quality of life(QOL) : To evaluate the QOL of median survival time and one year after the treatment.(2) Immunological parameters: CD4,CD8,CD4/CD8,peripheral blood leukocytes,antibody(IgA,IgG,IgM),alexin(C3),neutrophil.(3) Adverse reactions: chemoradiotherapy common adverse reactions such as nausea and vomiting.Results:Compared with the control group,the KPS and the median survival time of the treatment group were significantly different(P0.05) after a year of treatment,and the immune index of the treatment group were significant improved;especially the ratio of CD4/CD8,the count of complement(C3),peripheral leukocyte and the neutrophilic granulocyte were significantly different(P0.01).The incidence rate of adverse chemotherapy reactions of treatment group were significant decreased contrast with the control group(29% to 71%,P0.01).Conclusion:The application of sequential therapy of mannatide combined with chemotherapy significantly improved the patients’ life quality;enhanced the immunologic function comprehensively;reduced the incidence rate of adverse chemotherapy reactions;and had a better effect than the sequential therapy of thymosin.
出处 《中国医药导刊》 2013年第3期463-464,共2页 Chinese Journal of Medicinal Guide
关键词 甘露聚糖肽 序贯疗法 化疗 胃癌 Mannatide Sequential therapy Chemotherapy Gastric cancer
  • 相关文献

参考文献10

二级参考文献83

共引文献212

同被引文献29

  • 1王玉明,王玉芬,杨抚华,王浴生.多抗甲素对T-56细胞生长代谢的影响[J].中国抗生素杂志,1993,18(1):55-58. 被引量:8
  • 2李叶扬,刘锡麟,刘艺.烧伤病人血清渗透压和渗差的变化及其临床意义[J].中华整形烧伤外科杂志,1989,5(3):174-176. 被引量:3
  • 3宋刚,干信.甘露聚糖肽生物活性的研究进展[J].化学与生物工程,2007,24(4):14-16. 被引量:43
  • 4SFDA.中药新药临床研究指导原则(试行).北京:中国医药科技出版社,2002:168-172.
  • 5李小寒,尚小梅.基础护理学[M].第4版.北京:人民卫生出版社,2008:1.
  • 6郑丹.烧伤感染最常见的并发症[A].中华医学会、中华医学会烧伤外科学分会.中华医学会烧伤外科学分会2012年学术年会论文汇编[C].中华医学会,中华医学会烧伤外科学分会.2012:1.
  • 7王志勇,廖镇江,夏照帆,等.美罗培南治疗中、重度烧伤感染的临床观察[J].中国感染与经疗杂志,2007;3:191-193.
  • 8汪仕良.我国烧伤代谢营养研究50年简况[A].西南烧伤整形学会、费州省医学会.第八届西南五省一市烧伤整形学术会议暨贵州省医学会烧伤整形分会2010年学术年会论文汇编[C].西南烧伤整形学会,贵州省医学会,2010:5.
  • 9张小俊,史济湘.烧伤病人肌肉蛋白质分解的初步研究[J].中华整形烧伤外科杂志,1986;(2):284-287.
  • 10李慧瑛,计为明,屠军,等.参芪扶正注射液联合化疗治疗晚期胃癌的临床分析[J].中国医药导报,2013,10(15):99-101.

引证文献3

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部